アジア太平洋地域のトランスフェクション試薬および機器市場 – 2030 年までの業界動向と予測

Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Free Sample Report 無料サンプルレポート Inquire Before Buying 事前に問い合わせる Buy Now今すぐ購入

アジア太平洋地域のトランスフェクション試薬および機器市場 – 2030 年までの業界動向と予測

  • Medical Devices
  • Published Report
  • Mar 2023
  • Asia-Pacific
  • 350 ページ
  • テーブル数: 45
  • 図の数: 57

アジア太平洋地域のトランスフェクション試薬および機器市場

Market Size in USD Billion

CAGR :  % Diagram

Chart Image 0 0
Diagram 予測期間
1 –0
Diagram 市場規模(基準年)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Mirus Bio LLC.
  • Promega Corporation
  • Polyplus Transfection
  • Bio-Rad LaboratoriesInc.
  • Merck KGaA

アジア太平洋地域のトランスフェクション試薬および機器市場、製品別(試薬、キット、機器)、段階別(研究、前臨床、臨床段階、商業)、タイプ別(一過性トランスフェクション試薬および機器、安定トランスフェクション試薬および機器)、方法別(非ウイルス法およびウイルス法)、分子の種類別(プラスミド DNA、低分子干渉 RNA(siRNA)、タンパク質、DNA オリゴヌクレオチド、リボ核タンパク質複合体(RNP)、その他)、生物別(哺乳類細胞、植物、真菌、ウイルス、細菌)、用途別(インビトロ用途、インビボ用途、バイオプロダクション、その他)、エンドユーザー別(バイオ医薬品、CRO、(CMO/CDMO)、学術機関、病院、臨床検査室、その他)、流通チャネル別(直接入札、小売販売、その他)、2030 年までの業界動向および予測

アジア太平洋地域のトランスフェクション試薬および装置市場

アジア太平洋地域のトランスフェクション試薬および機器市場の分析と洞察

トランスフェクションでは、ウイルスおよび非ウイルスの方法により真核細胞に核酸を導入します。トランスフェクション法は、負に帯電した膜を移動させるという課題を克服できます。リン酸カルシウムやジエチルアミノエチル (DEAE) デキストラン、またはカチオン性脂質ベースの試薬などの化学物質は、DNA の外側のコートと反応します。これにより、全体の負電荷が中和され、分子に正の電荷が付与されるため、DNA の送達が可能になります。エレクトロポレーションなどの物理的方法では、電圧を印加することで細胞膜に微細な孔が作られ、DNA が細胞質に直接入り込むことができます。DEAE デキストランは一過性のトランスフェクションに使用されますが、リポフェクションでは安定したトランスフェクションが達成できるため、長期的なタンパク質発現に使用できます。リン酸カルシウムを介したトランスフェクションも、安定したトランスフェクションに使用できます。ウイルスによるトランスフェクション法は効率が高く、医薬品開発のいくつかの段階で使用されます。

アジア太平洋地域のトランスフェクション試薬および装置市場

アジア太平洋地域のトランスフェクション試薬および装置市場

トランスフェクション法は、農作物の保護や収穫量の増加、風味や香りを高める合成生物学製品の製造、単細胞タンパク質の強化など、農業に関わるさまざまな用途に使用されています。トランスフェクションの需要は先進国と発展途上国の両方で増加しており、その背景には慢性疾患の発生の増加があります。トランスフェクション市場は、キメラ遺伝子の需要の増加とタンパク質製造におけるバイオ医薬品の利用により成長しています。市場は、新興市場の探索、市場プレーヤーによる戦略的イニシアチブ、および政府支援の増加により、予測期間中に成長するでしょう。

機器の高コスト、トランスフェクション試薬の選択的有効性、およびトランスフェクション方法によって引き起こされる細胞損傷により、アジア太平洋地域のトランスフェクション試薬および機器市場の成長が抑制されると予想されます。

市場は、買収、コラボレーション、パートナーシップを含む市場プレーヤーによるいくつかの戦略的取り組みにより成長しています。

Data Bridge Market Researchは、アジア太平洋地域のトランスフェクション試薬および機器市場は、予測期間中に10.7%のCAGRで成長し、2030年までに3億5,828万4,090米ドルの価値に達すると予測しています。

レポートメトリック

詳細

予測期間

2023年から2030年

基準年

2022

歴史的な年

2021 (2020~2016年にカスタマイズ可能)

定量単位

売上高(千単位)、販売数量(個数)、価格(米ドル)

対象セグメント

製品別(試薬、キット、機器)、段階別(研究、前臨床、臨床段階、商用)、タイプ別(一過性トランスフェクション試薬および機器、安定トランスフェクション試薬および機器)、方法別(非ウイルス法およびウイルス法)、分子の種類別(プラスミド DNA、低分子干渉 RNA(siRNA)、タンパク質、DNA オリゴヌクレオチド、リボ核タンパク質複合体(RNP)、その他)、生物別(哺乳類細胞、植物、真菌、ウイルス、細菌)、用途別(in vitro 用途、in vivo 用途、バイオプロダクション、その他)、エンドユーザー別(バイオ医薬品、CRO、(CMO/CDMO)、学術機関、病院、臨床研究室、その他)、流通チャネル別(直接入札、小売販売、その他)。

対象国

中国、日本、インド、オーストラリア、韓国、シンガポール、タイ、マレーシア、フィリピン、インドネシア、およびその他のアジア太平洋地域。

対象となる市場プレーヤー

Mirus Bio LLC.、Promega Corporation、Polyplus Transfection、Bio-Rad Laboratories, Inc.、Merck KGaA、Lonza、MaxCyte, Inc.、Altogen Biosystems、SBS Genetech、FUJIFILM Irvine Scientific(FUJIFILM Holdings Corporation の子会社)、Avanti Polar Lipids(Croda International Plc の子会社)、PerkinElmer chemagen Technologie GmbH(PerkinElmer Inc. の子会社)、Cytiva、Geno Technology Inc.、USA、R&D Systems, Inc.、Takara Bio Inc.、Thermofisher Scientific Inc.、Roche Molecular Systems, Inc.(F. Hoffmann-La Roche Ltd の子会社)、QIAGEN、OriGene Technologies, Inc.、Applied Biological Materials Inc.(abm)、Beckman Coulter, Inc.(Danaher の子会社)、Amyris、 Codexis、Autolus、SignaGen Laboratories、Impossible Foods Inc.、Genlantis Inc.、Ginkgo Bioworks、Verve Therapeutics、Inc.、Conagen、Inc.、Poseida Therapeutics、Inc.、Twist Bioscience など。

市場の定義

トランスフェクション法は、RNA、DNA、またはタンパク質産物を細胞に導入して、生物の表現型と遺伝子型を変更するために使用されます。トランスフェクション法には、新しい遺伝子の転送、またはゲノム編集の目的でクラスター化された規則的に間隔を置いた短い回文反復配列 (CRISPR) などの遺伝子構造の転送が含まれます。トランスフェクションは、免疫療法、遺伝子治療、 細胞治療などの分野で幅広く使用されています。トランスフェクションには、非ウイルス性およびウイルス媒介性トランスフェクションの両方が含まれます。化学的および物理的方法により、非ウイルス性トランスフェクションを実現できます。トランスフェクションに使用される最も一般的な化学的方法は、リン酸カルシウムトランスフェクション、リポソームトランスフェクションなどです。ウイルストランスフェクションは高いトランスフェクション効率をもたらし、トランスフェクションに使用されるさまざまなタイプの物理的方法には、マイクロインジェクション、微粒子銃送達、およびエレクトロポレーションがあり、その中でもエレクトロポレーションは高いトランスフェクション効率をもたらします。トランスフェクションには、一過性トランスフェクションと安定トランスフェクションの 2 種類があります。遺伝子ノックアウト研究などの短期的な遺伝子発現研究では、小規模生産の一過性トランスフェクション法が好まれますが、長期研究研究や大規模なタンパク質生産の安定トランスフェクション法が広く採用されています。

アジア太平洋地域のトランスフェクション試薬および機器市場の動向

このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらについては、以下で詳しく説明します。    

ドライバー

  • 慢性疾患の罹患率の上昇

慢性疾患の罹患率は世界中で増加しており、効果的で正確な治療が求められています。トランスフェクションは、標的を絞った改変遺伝子を送達して、いくつかの遺伝性疾患を治療するために使用されます。トランスフェクション法は、適応免疫を強化し、さまざまな疾患を予防できる CRISPR 遺伝子の送達にも使用されます。

COVID-19やその他の感染症などの慢性疾患の増加により、欠陥のある遺伝子を正しい遺伝子に置き換えることができる効果的な遺伝子治療製品の発見につながっています。トランスフェクション法は、とりわけ遺伝子治療に広く使用されています。効果的で正確な治療の需要が世界中で高まるにつれて、遺伝子治療とトランスフェクション法の需要も高まっています。さらに、遺伝子治療が慢性疾患の治療に可能性があることを証明する進行中の研究もいくつかあり、医師と患者の間での需要も高まっています。したがって、これは慢性疾患の有病率の上昇がアジア太平洋地域のトランスフェクション試薬および機器市場の成長の原動力となっていることを意味します。

  • 合成生物学製品の開発

Synthetic biology is a new era of biology that incorporates the engineering principle into biology. Synthetic biology involves the chemical synthesis of DNA by combining the knowledge of genomics to reassemble the DNA genomes. The synthetic biology that sequences into the new genes involves genetic engineering, which incorporates the transfection method, among others. As the demand for synthetic biology products is increasing worldwide, the use of transfection products is also increasing.

The demand for synthetic biology products is increasing due to the increasing demand for effective and innovative products. The manufacturing of synthetic products enhances the demand for transfection products, as gene transfer can be accompanied by the transfection method, among others. Thus, this signifies that synthetic product development drives the Asia-Pacific transfection Reagent and equipment market growth.

Restraint

  • CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE

Some transfection methods have been reported to cause cell damage, reducing the reproducibility of the overall method. Among the several kinds of transfection procedures, electroporation has been reported to cause maximum cell damage as per the increase in voltage. This cell damage lowers the efficiency rate and impacts the ongoing project.

One of the most common side effects of the transfection procedure is cell damage which lowers the cells metabolic events and leads to cell death. This damaged cell can enhance the media toxicity and hence produces inappropriate results. Thus, this suggests that cell damage induced by the transfection procedure acts as a restraint for the Asia-Pacific transfection Reagent and equipment market growth.

Opportunity

  • EXPLORATION OF EMERGING MARKET

The transfection products have been shown as promising tools for the genetic engineering and proteomic industry. The top market for transfection products is in Europe and North America. By looking at the positive outcomes of these products, many market players are penetrating their roots in growing economies involving China and India, among others. The emerging market allows these market players to combat the loss that arises from the well-established market.

As emerging markets allow the market players to overcome the economic downturn specified to particular established markets, investment and exploration of emerging markets allow the market players to engage in the development and manufacturing of transfection products to attain lucrative growth. Thus, this signifies that exploring emerging markets is an opportunity to grow the Asia-Pacific transfection Reagent and equipment market.

Challenge

  • LONG APPROVAL PROCEDURE

The long approval procedure for transfection Reagent and instruments is a hindering agent for the growth of the transfection market. Transfection products are subjected to extensive regulations and have to monitor every time. The transfection products are widely used for the insertion of desired gene molecules in a particular cell line to obtain proteins and other biological compounds. This process is thus investigated and approved by the long and strict regulatory procedures. The long process required to get a positive result from every conducted clinical trial led to more time consumption and the investment of lots of money by market players.

The transfection Reagent are mostly subjected to 21CFR parts 210 and 211 U.S. FDA guidelines, according to which the manufacturers had to assure that the reagent manufactured meets the safety, packaging and processing characteristics proposed by the regulatory agencies. The owner or manufacturer has to submit licenses under section 351 of the PHS (Public Health Services) Act, which is quite a tedious procedure. Thus, this signifies that long approval procedures challenge the Asia-Pacific transfection Reagent and equipment market growth.

Recent Developments

  • In August 2021, Mirus Bio expanded the TransIT VirusGen platform for Good Manufacturing Practice (GMP) viral vector production to support cell and gene therapy development, process operations, and commercial production. The extension, referred to as TransIT VirusGen GMP Transfection Reagent, is designed to improve the packaging and delivery of vector DNA to suspension and adherent HEK 293 cell types to improve the production of recombinant adeno-associated viruses and lentiviral vectors.
  • In April 2021, BOC Sciences announced the launch of two in vivo RNA transfection kits, namely siRNA in vivo transfection kits and mRNA in vivo transfection kits, suitable for in vivo transfection of siRNA and mRNA, respectively.

Asia-Pacific Transfection Reagent and Equipment Market Scope

Asia-Pacific transfection Reagent and equipment market is segmented into nine notable segments such as products, stage, methods, type, types of molecule, application, end user, organism, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.  

PRODUCTS

  • INSTRUMENTS
  • REAGENT & KITS

On the basis of products, the Asia-Pacific transfection reagent and equipment market is segmented into instruments and reagent & kits.

STAGE

  • RESEARCH
  • PRECLINICAL
  • CLINICAL PHASES
  • COMMERCIAL

On the basis of stage, the Asia-Pacific transfection reagent and equipment market is segmented into research, preclinical, clinical phases and commercial.

TYPE

  • TRANSIENT TRANSFECTION REAGENT AND EQUIPMENT
  • STABLE TRANSFECTION REAGENT AND EQUIPMENT

On the basis of type, the Asia-Pacific transfection reagent and equipment market is segmented into transient transfection reagent and equipment and stable transfection reagent and equipment.

METHODS

  • NON-VIRAL METHODS
  • VIRAL METHODS

On the basis of methods, the Asia-Pacific transfection reagent and equipment market is segmented into non-viral methods and viral methods.

TYPES OF MOLECULE

  • PLASMID DNA
  • DNA OLIGONUCLEOTIDES
  • SMALL INTERFERING RNA (SIRNA)
  • PROTEINS
  • RIBONUCLEOPROTEIN COMPLEXES (RNPS)
  • OTHERS

On the basis of types of molecule, the Asia-Pacific transfection reagent and equipment market is segmented into plasmid DNA, DNA oligonucleotides, small interfering RNA (siRNA), proteins, ribonucleoprotein complexes (RNPs) and others.

ORGANISM

  • BACTERIA
  • MAMMALIAN CELLS
  • FUNGI
  • PLANTS
  • VIRUS

On the basis of organism, the Asia-Pacific transfection reagent and equipment market is segmented into bacteria, mammalian cells, fungi, plants and virus.

APPLICATION

  • BY TYPE
    • IN VITRO APPLICATION
    • IN VIVO APPLICATION
    • BIOPRODUCTION
    • OTHERS
  • BY INDUSTRY
    • AGRICULTURE
    • SYNTHETIC BIOLOGY
    • OTHERS

On the basis of application, the Asia-Pacific transfection reagent and equipment market is segmented by type into in vitro application, in vivo application, bioproduction, others and by industry into agriculture, synthetic biology, others.

END USER

  • BIOPHARMA
  • CROS
  • CMOS/CDMOS
  • ACADEMIA
  • HOSPITALS
  • CLINICAL LABS
  • OTHERS

On the basis of end user, the Asia-Pacific transfection reagent and equipment market is segmented into biopharma, CROs, CMOs/ CDMOs, academia, hospitals, clinical labs and others.

DISTRIBUTION CHANNEL

  • DIRECT TENDER
  • RETAIL SALES
  • OTHERS

On the basis of distribution channel, the Asia-Pacific transfection Reagent and equipment market is segmented into direct tender, retail sales and others.

Asia-Pacific Transfection Reagent and Equipment Market Regional Analysis/Insights

The Asia-Pacific transfection reagent and equipment market is categorized into many notable segments such as geography, products, stages, methods, type, types of molecule, application, end user, organism, and distribution channel.

The countries covered in this market report are China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Philippines, Indonesia, and Rest of Asia-Pacific.

In 2023, China dominates Asia-Pacific region due to increasing customer inclinations towards advanced technological processes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

競争環境とアジア太平洋地域のトランスフェクション試薬および機器市場シェア分析

アジア太平洋地域のトランスフェクション試薬および機器市場の競争状況では、競合他社ごとに詳細が提供されます。詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品の承認、製品の幅と幅、アプリケーションの優位性、製品タイプのライフライン曲線が含まれます。上記のデータ ポイントは、アジア太平洋地域のトランスフェクション試薬および機器市場への会社の重点にのみ関連しています。

この市場で活動している主な企業としては、Mirus Bio LLC、Promega Corporation、Polyplus Transfection、Bio-Rad Laboratories, Inc.、Merck KGaA、Lonza、MaxCyte, Inc.、Altogen Biosystems、SBS Genetech、FUJIFILM Irvine Scientific(FUJIFILM Holdings Corporation の子会社)、Avanti Polar Lipids(Croda International Plc の子会社)、PerkinElmer chemagen Technologie GmbH(PerkinElmer Inc. の子会社)、Cytiva、Geno Technology Inc.、USA、R&D Systems, Inc.、Takara Bio Inc.、Thermofisher Scientific Inc.、Roche Molecular Systems, Inc.(F. Hoffmann-La Roche Ltd の子会社)、QIAGEN、OriGene Technologies, Inc.、Applied Biological Materials Inc.(abm)、Beckman Coulter, Inc.(ダナハー社、アミリス社、コデキシス社、オートラス社、シグナジェン・ラボラトリーズ社、インポッシブル・フーズ社、ジェンランティス社、ギンゴ・バイオワークス社、ヴァーヴ・セラピューティクス社、コナジェン社、ポセイダ・セラピューティクス社、ツイスト・バイオサイエンス社など。


SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TRANSIENT TRANSFECTION OF TRANSFECTION LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL

4.2 PORTER'S FIVE FORCES MODEL

5 INDUSTRY INSIGHTS:

6 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET, REGULATIONS

6.1 EUROPEAN UNION REGULATORY SCENARIO

6.2 U.S. REGULATORY SCENARIO

6.3 JAPAN REGULATORY SCENARIO

6.4 CHINA REGULATORY SCENARIO

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISE IN THE PREVALENCE OF CHRONIC DISEASES

7.1.2 DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS

7.1.3 GROWING DEMAND FOR CHIMERIC GENES

7.1.4 LARGE-SCALE TRANSFECTIONS USED IN CLINICAL RESEARCH

7.1.5 UTILIZATION OF BIOPHARMACEUTICALS IN THE PRODUCTION OF PROTEINS

7.2 RESTRAINTS

7.2.1 HIGH COST OF TRANSFECTION PRODUCTS

7.2.2 SELECTIVE EFFECTIVENESS OF TRANSFECTION REAGENTS

7.2.3 CELL DAMAGE INDUCED BY TRANSFECTION PROCEDURE

7.3 OPPORTUNITIES

7.3.1 EXPLORATION OF EMERGING MARKET

7.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS

7.3.3 SURGING LEVEL OF INVESTMENT

7.4 CHALLENGES

7.4.1 LONG APPROVAL PROCEDURE

7.4.2 LACK OF SAFETY LEVEL LAB FOR VIRUS-ASSOCIATED TRANSFECTION

7.4.3 LACK OF TRAINED PROFESSIONALS

8 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS

8.1 OVERVIEW

8.2 REAGENTS & KITS

8.3 INSTRUMENTS

9 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE

9.1 OVERVIEW

9.2 RESEARCH

9.3 PRECLINICAL

9.4 CLINICAL PHASES

9.5 COMMERCIAL

10 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE

10.1 OVERVIEW

10.2 TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT

10.3 STABLE TRANSECTION REAGENTS AND EQUIPMENT

11 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY METHODS

11.1 OVERVIEW

11.2 NON-VIRAL METHODS

11.3 VIRAL METHODS

12 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE

12.1 OVERVIEW

12.2 PLASMID DNA

12.3 SMALL INTERFERING RNA (SIRNA)

12.4 PROTEINS

12.5 DNA OLIGONUCLEOTIDES

12.6 RIBONUCLEOPROTEIN COMPLEXES (RNPS)

12.7 OTHERS

13 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM

13.1 OVERVIEW

13.2 MAMMALIAN CELLS

13.3 PLANTS

13.4 FUNGI

13.5 VIRUS

13.6 BACTERIA

14 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 IN VITRO APPLICATION

14.2.1 IN VIVO APPLICATION

14.2.2 BIOPRODUCTION

14.2.3 OTHERS

14.2.4 SYNTHETIC BIOLOGY

14.2.5 AGRICULTURE

14.2.6 OTHERS

15 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER

15.1 OVERVIEW

15.2 BIOPHARMA

15.3 CROS

15.4 CMOS/CDMOS

15.5 ACADEMIA

15.6 HOSPITALS

15.7 CLINICAL LABS

15.8 OTHERS

16 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 RETAIL SALES

16.4 OTHERS

17 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION

17.1 ASIA PACIFIC

17.1.1 CHINA

17.1.2 JAPAN

17.1.3 INDIA

17.1.4 AUSTRALIA

17.1.5 SOUTH KOREA

17.1.6 SINGAPORE

17.1.7 THAILAND

17.1.8 MALAYSIA

17.1.9 INDONESIA

17.1.10 PHILIPPINES

17.1.11 REST OF ASIA-PACIFIC

18 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET, COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

19 SWOT ANALYSIS

20 COMPANY PROFILE

20.1 THERMO FISHER SCIENTIFIC INC.

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 COMPANY SHARE ANALYSIS

20.1.4 PRODUCT PORTFOLIO

20.1.5 RECENT DEVELOPMENT

20.2 ROCHE MOLECULAR SYSTEMS, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 COMPANY SHARE ANALYSIS

20.2.4 PRODUCT PORTFOLIO

20.2.5 RECENT DEVELOPMENT

20.3 PROMEGA CORPORATION

20.3.1 COMPANY SNAPSHOT

20.3.2 COMPANY SHARE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENT

20.4 TAKARA BIO INC.

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 COMPANY SHARE ANALYSIS

20.4.4 PRODUCT PORTFOLIO

20.4.5 RECENT DEVELOPMENT

20.5 BIO-RAD LABORATORIES, INC.

20.5.1 COMPANY SNAPSHOT

20.5.2 REVENUE ANANLYSIS

20.5.3 COMPANY SHARE ANALYSIS

20.5.4 PRODUCT PORTFOLIO

20.5.5 RECENT DEVELOPMENT

20.6 ALTOGEN BIOSYSTEMS

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 APPLIED BIOLOGICAL MATERIALS INC. (ABM)

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENT

20.8 AVANTI POLAR LIPIDS (A SUBSIDIARY OF CRODA INTERNATIONAL PLC)

20.8.1 COMPANY SNAPSHOT

20.8.2 REVENUE ANALYSIS

20.8.3 PRODUCT PORTFOLIO

20.8.4 RECENT DEVELOPMENT

20.9 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENT

20.1 CYTIVA

20.10.1 COMPANY SNAPSHOT

20.10.2 PRODUCT PORTFOLIO

20.10.3 RECENT DEVELOPMENT

20.11 FUJIFILM IRVINE SCIENTIFIC (A SUBSIDIARY OF FUJIFILM HOLDINGS CORPORATION)

20.11.1 COMPANY SNAPSHOT

20.11.2 REVENUE ANANLYSIS

20.11.3 PRODUCT PORTFOLIO

20.11.4 RECENT DEVELOPMENT

20.12 GENLANTIS INC.

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENT

20.13 GENO TECHNOLOGY INC., USA

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENT

20.14 GINKGO BIOWORKS

20.14.1 COMPANY SNAPSHOT

20.14.2 PRODUCT PORTFOLIO

20.14.3 RECENT DEVELOPMENTS

20.15 LONZA

20.15.1 COMPANY SNAPSHOT

20.15.2 REVENUE ANANLYSIS

20.15.3 PRODUCT PORTFOLIO

20.15.4 RECENT DEVELOPMENT

20.16 MAXCYTE, INC.

20.16.1 COMPANY SNAPSHOT

20.16.2 REVENUE ANALYSIS

20.16.3 PRODUCT PORTFOLIO

20.16.4 RECENT DEVELOPMENT

20.17 MERCK KGAA

20.17.1 COMPANY SNAPSHOT

20.17.2 REVENUE ANALYSIS

20.17.3 PRODUCT PORTFOLIO

20.17.4 RECENT DEVELOPMENT

20.18 MIRUS BIO LLC.

20.18.1 COMPANY SNAPSHOT

20.18.2 PRODUCT PORTFOLIO

20.18.3 RECENT DEVELOPMENT

20.19 ORIGENE TECHNOLOGIES, INC.

20.19.1 COMPANY SNAPSHOT

20.19.2 PRODUCT PORTFOLIO

20.19.3 RECENT DEVELOPMENT

20.2 PERKINELMER CHEMAGEN TECHNOLOGIE GMBH (A SUBSIDIARY OF PERKINELMER INC.)

20.20.1 COMPANY SNAPSHOT

20.20.2 REVENUE ANALYSIS

20.20.3 PRODUCT PORTFOLIO

20.20.4 RECENT DEVELOPMENT

20.21 POLYPLUS TRANSFECTION

20.21.1 COMPANY SNAPSHOT

20.21.2 PRODUCT PORTFOLIO

20.21.3 RECENT DEVELOPMENT

20.22 R&D SYSTEMS, INC.

20.22.1 COMPANY SNAPSHOT

20.22.2 PRODUCT PORTFOLIO

20.22.3 RECENT DEVELOPMENT

20.23 SBS GENETECH

20.23.1 COMPANY SNAPSHOT

20.23.2 PRODUCT PORTFOLIO

20.23.3 RECENT DEVELOPMENT

20.24 SIGNAGEN LABORATORIES

20.24.1 COMPANY SNAPSHOT

20.24.2 PRODUCT PORTFOLIO

20.24.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

表のリスト

TABLE 1 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY PRODUCTS, 2021-2030 (USD THOUSAND)

TABLE 2 ASIA-PACIFIC REAGENT AND KITS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 3 ASIA-PACIFIC INSTRUMENTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 4 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY STAGE, 2021-2030 (USD THOUSAND)

TABLE 5 ASIA-PACIFIC RESEARCH IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 6 ASIA-PACIFIC PRECLINICAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 7 ASIA-PACIFIC CLINICAL PHASES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 8 ASIA-PACIFIC COMMERCIAL IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 9 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPE, 2021-2030 (USD THOUSAND)

TABLE 10 ASIA-PACIFIC TRANSIENT TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 11 ASIA-PACIFIC STABLE TRANSFECTION REAGENTS AND EQUIPMENT IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 12 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET, BY METHODS, 2021-2030 (USD THOUSAND)

TABLE 13 ASIA-PACIFIC NON-VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 14 ASIA-PACIFIC VIRAL METHODS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 15 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY TYPES OF MOLECULE, 2021-2030 (USD THOUSAND)

TABLE 16 ASIA-PACIFIC PLASMID DNA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 17 ASIA-PACIFIC SMALL INTERFERING RNA (SIRNA) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 18 ASIA-PACIFIC PROTEINS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 19 ASIA-PACIFIC DNA OLIGONUCLEOTIDES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 20 ASIA-PACIFIC RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 21 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 22 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY ORGANISM, 2021-2030 (USD THOUSAND)

TABLE 23 ASIA-PACIFIC MAMMALIAN CELLS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 24 ASIA-PACIFIC PLANTS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 25 ASIA-PACIFIC FUNGI IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 26 ASIA-PACIFIC VIRUS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 27 ASIA-PACIFIC BACTERIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 28 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET , BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 29 ASIA-PACIFIC IN VITRO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 30 ASIA-PACIFIC IN VIVO APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 31 ASIA-PACIFIC BIOPRODUCTION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 32 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 33 ASIA-PACIFIC APPLICATION IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY INDUSTRY, 2021-2030 (USD THOUSAND)

TABLE 34 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 35 ASIA-PACIFIC BIOPHARMA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 36 ASIA-PACIFIC CROS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 37 ASIA-PACIFIC CMOS/CDMOS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 38 ASIA-PACIFIC ACADEMIA IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 39 ASIA-PACIFIC HOSPITALS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 40 ASIA-PACIFIC CLINICAL LABS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 41 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 42 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 43 ASIA-PACIFIC DIRECT TENDER IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 44 ASIA-PACIFIC RETAIL SALES IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

TABLE 45 ASIA-PACIFIC OTHERS IN TRANSFECTION REAGENT AND EQUIPMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND)

図表一覧

FIGURE 1 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MULTIVARIATE MODELLING

FIGURE 7 ASIA-PACIFIC TRANSFECTION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: SEGMENTATION

FIGURE 12 INCREASING OCCURENCE OF CHRONIC DISEASES AND DEVELOPMENT OF SYNTHETIC BIOLOGY PRODUCTS IS DRIVING THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2022 TO 2030

FIGURE 13 THE TRANSIENT TRANSFECTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET IN 2022 & 2030

FIGURE 14 APPROVAL PROCESS FOR GENE THERAPY IN CHINA

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET

FIGURE 16 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023

FIGURE 17 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, 2023-2030 (USD THOUSAND)

FIGURE 18 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, CAGR (2023-2030)

FIGURE 19 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 20 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023

FIGURE 21 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, 2023-2030 (USD THOUSAND)

FIGURE 22 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, CAGR (2023-2030)

FIGURE 23 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY STAGE, LIFELINE CURVE

FIGURE 24 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023

FIGURE 25 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, 2023-2030 (USD THOUSAND)

FIGURE 26 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, CAGR (2023-2030)

FIGURE 27 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE

FIGURE 28 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2022

FIGURE 29 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, 2023-2030 (USD THOUSAND)

FIGURE 30 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, CAGR (2023-2030)

FIGURE 31 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: BY METHODS, LIFELINE CURVE

FIGURE 32 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2022

FIGURE 33 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, 2023-2030 (USD THOUSAND)

FIGURE 34 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, CAGR (2023-2030)

FIGURE 35 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY TYPES OF MOLECULE, LIFELINE CURVE

FIGURE 36 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2022

FIGURE 37 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, 2023-2030 (USD THOUSAND)

FIGURE 38 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, CAGR (2023-2030)

FIGURE 39 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY ORGANISM, LIFELINE CURVE

FIGURE 40 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2022

FIGURE 41 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, 2023-2030 (USD THOUSAND)

FIGURE 42 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, CAGR (2023-2030)

FIGURE 43 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET BY APPLICATION, LIFELINE CURVE

FIGURE 44 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY END USER, 2022

FIGURE 45 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, 2023-2030 (USD THOUSAND)

FIGURE 46 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, CAGR (2023-2030)

FIGURE 47 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET : BY END USER, LIFELINE CURVE

FIGURE 48 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 49 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)

FIGURE 50 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 51 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 52 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: SNAPSHOT (2022)

FIGURE 53 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022)

FIGURE 54 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2023 & 2030)

FIGURE 55 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY COUNTRY (2022 & 2030)

FIGURE 56 ASIA-PACIFIC TRANSFECTION REAGENT AND EQUIPMENT MARKET: BY PRODUCTS (2023-2030)

FIGURE 57 ASIA-PACIFIC TRANSFECTION REAGENTS AND EQUIPMENT MARKET: COMPANY SHARE 2022 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Testimonial